Identification of rare sequence variation underlying heritable pulmonary arterial hypertensionStefan Gräf, Nicholas W. Morrell, Dan F. Stein et al.|Nature Communications|2018Cited by 382
Plasma Metabolomics Implicates Modified Transfer RNAs and Altered Bioenergetics in the Outcomes of Pulmonary Arterial HypertensionChristopher J. Rhodes, Martin R. Wilkins, Pavandeep Ghataorhe et al.|Circulation|2016Cited by 214
Genetic determinants of risk in pulmonary arterial hypertension: international genome-wide association studies and meta-analysisChristopher J. Rhodes, Stefano Ghio, Ken Batai et al.|The Lancet Respiratory Medicine|2018Cited by 212
A systematic CRISPR screen defines mutational mechanisms underpinning signatures caused by replication errors and endogenous DNA damageXueqing Zou, Athanasios Kousathanas, Gene Ching Chiek Koh et al.|Nature Cancer|2021Cited by 165
Phenotypic Characterization of <i>EIF2AK4</i> Mutation Carriers in a Large Cohort of Patients Diagnosed Clinically With Pulmonary Arterial HypertensionCharaka Hadinnapola, Taco W. Kuijpers, Marta Bleda et al.|Circulation|2017Cited by 144